The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat

FTS is effective in suppressing the progression of EAM and its consequent functional myocardial dysfunction. The effect may be mediated by suppression of the cellular and humoral responses to myosin.